Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Pilot study shows apremilast effective for severe recurrent canker sores

Key clinical point: Apremilast showed high efficacy in treating patients with recurrent aphthous stomatitis.

Major finding: Within 4 weeks of therapy, complete clearance of lesions was observed in the majority of patients.

Study details: A pilot study of 15 patients with recurrent aphthous stomatitis.

Disclosures: The study was supported by Celgene. The researchers reported having no financial disclosures.

Citation:

Bruce AJ et al. AAD 20, Abstract 17701.